GeneCentric Therapeutics

Gene Centric Therapeutics

Biotechnology, 280 S Mangum St, Research Triangle Park, North Carolina, 27701, United States, 11-50 Employees

genecentric.com

  • twitter
  • LinkedIn

phone no Phone Number: 91********

Who is GENECENTRIC THERAPEUTICS

GeneCentric was founded based on intellectual property from Drs. Neil Hayes and Chuck Perous laboratories at the Lineberger Comprehensive Cancer Center at the UNC School of Medicine. Gene...

Read More

map
  • 280 S Mangum St, Research Triangle Park, North Carolina, 27701, United States Headquarters: 280 S Mangum St, Research Triangle Park, North Carolina, 27701, United States
  • 2011 Date Founded: 2011
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies
  • Michael Milburn CEO:   Michael Milburn

industries-icon Industry: Biotechnology

SIC SIC Code: 3829 | NAICS Code: 621512 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GENECENTRIC THERAPEUTICS

GeneCentric Therapeutics Org Chart and Mapping

Employees

John Guo

Senior Bioinformatics Scientist

Joshua Uronis

Genomics Sequencing Operations Director at Genecentric Therapeutics, Inc.

Kirk Beebe

VP, Discovery and Translational Science

Jeffery Burdine

Sr. Director Information Technology

Brian Kelly

Senior Vice President Business Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding GeneCentric Therapeutics

Answer: GeneCentric Therapeutics's headquarters are located at 280 S Mangum St, Research Triangle Park, North Carolina, 27701, United States

Answer: GeneCentric Therapeutics's phone number is 91********

Answer: GeneCentric Therapeutics's official website is https://genecentric.com

Answer: GeneCentric Therapeutics's revenue is $10 Million to $25 Million

Answer: GeneCentric Therapeutics's SIC: 3829

Answer: GeneCentric Therapeutics's NAICS: 621512

Answer: GeneCentric Therapeutics has 11-50 employees

Answer: GeneCentric Therapeutics is in Biotechnology

Answer: GeneCentric Therapeutics contact info: Phone number: 91******** Website: https://genecentric.com

Answer: GeneCentric was founded based on intellectual property from Drs. Neil Hayes and Chuck Perous laboratories at the Lineberger Comprehensive Cancer Center at the UNC School of Medicine. GeneCentric currently has two unique platform technologies: The Lung Subtype Platform (LSPTM) stratifies lung cancer patients into subtypes, which are important for appropriate therapeutic selection. The first application of LSPTM was licensed to and independently developed by Laboratory Corporation of America Holdings (LabCorp) and is now available through its specialty testing business, Integrated Oncology, as HistoPlusSM: Lung Cancer. GeneCentrics second platform technology is the Hypoxia Signature which has the potential to identify patients that respond to anti-angiogenesis therapies. GeneCentric utilizes a unique partnership model to translate important cancer discoveries into clinically adopted diagnostics for pathologists, clinicians, and, most importantly, patients. By partnering with the foremost clinical laboratories, in-vitro diagnostic (IVD), pharmaceutical, and biotech companies, GeneCentric can focus on its core strength, exceptional science and clinical studies, building evidence for the utility of its unique assays.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access